Amedeo Amedei

T helper type 1 lymphocytes drive inflammation in human atherosclerotic lesions.

Helicobacter pylori antigen-specific T-cell responses at gastric level in chronic gastritis, peptic ulcer, gastric cancer and low-grade mucosa-associated lymphoid tissue (MALT) lymphoma.

Molecular mimicry between Helicobacter pylori antigens and H+, K+ --adenosine triphosphatase in human gastric autoimmunity.

Helicobacter pylori cag pathogenicity island is associated with reduced expression of interleukin-4 (IL-4) mRNA and modulation of the IL-4delta2 mRNA isoform in human gastric mucosa.

The Helicobacter pylori vacuolating toxin inhibits T cell activation by two independent mechanisms.

Gastric autoimmunity: the role of Helicobacter pylori and molecular mimicry.

Helicobacter pylori and gastric autoimmunity.

IFN-gamma-inducible protein 10 and pentraxin 3 plasma levels are tools for monitoring inflammation and disease activity in Mycobacterium tuberculosis infection.

Molecular specificity and functional properties of autoreactive T-cell response in human gastric autoimmunity.

Helicobacter pylori, T cells and cytokines: the "dangerous liaisons".

Human 60-kDa heat shock protein is a target autoantigen of T cells derived from atherosclerotic plaques.

The neutrophil-activating protein of Helicobacter pylori promotes Th1 immune responses.

The neutrophil-activating protein of Helicobacter pylori (HP-NAP) as an immune modulating agent.

Identification of a posttranslational mechanism for the regulation of hERG1 K+ channel expression and hERG1 current density in tumor cells.

Immunosuppression of TH2 responses in Trichinella spiralis infection by Helicobacter pylori neutrophil-activating protein.

Helicobacter pylori, asthma and allergy.

Characterization of tumor antigen peptide-specific T cells isolated from the neoplastic tissue of patients with gastric adenocarcinoma.

New frontiers in cell-based immunotherapy of cancer.

zeta-Crystallin is a bcl-2 mRNA binding protein involved in bcl-2 overexpression in T-cell acute lymphocytic leukemia.

Targeting IL-23 in human diseases.

The effect of Helicobacter pylori on asthma and allergy.

Role of immune response in Yersinia pestis infection.

T-cell response to bacterial agents.

T cells and adoptive immunotherapy: recent developments and future prospects in gastrointestinal oncology.

Chlamydophila pneumoniae phospholipase D (CpPLD) drives Th17 inflammation in human atherosclerosis.

Mucin depleted foci, colonic preneoplastic lesions lacking Muc2, show up-regulation of Tlr2 but not bacterial infiltration.

Novel immunotherapeutic strategies of gastric cancer treatment.

T cells in gastric cancer: friends or foes.

The use of cytokines and chemokines in the cancer immunotherapy.

Potential role of M. tuberculosis specific IFN-γ and IL-2 ELISPOT assays in discriminating children with active or latent tuberculosis.

Helicobacter pylori secreted peptidyl prolyl cis, trans-isomerase drives Th17 inflammation in gastric adenocarcinoma.

Multiple sclerosis: the role of cytokines in pathogenesis and in therapies.

What is recent in pancreatic cancer immunotherapy?

Ex vivo analysis of pancreatic cancer-infiltrating T lymphocytes reveals that ENO-specific Tregs accumulate in tumor tissue and inhibit Th1/Th17 effector cell functions.

Nicotinamide phosphoribosyltransferase (NAMPT) activity is essential for survival of resting lymphocytes.

Broad targeting of angiogenesis for cancer prevention and therapy.

Evasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds.

Cancer prevention and therapy through the modulation of the tumor microenvironment.

Therapeutic targeting of replicative immortality.

Genomic instability in human cancer: Molecular insights and opportunities for therapeutic attack and prevention through diet and nutrition.

Thrombosis in vasculitis: from pathogenesis to treatment.

Sustained proliferation in cancer: Mechanisms and novel therapeutic targets.

Broad targeting of resistance to apoptosis in cancer.

A multi-targeted approach to suppress tumor-promoting inflammation.

Microparticles: Bridging the Gap between Autoimmunity and Thrombosis.

Gastric cancer and the epoch of immunotherapy approaches.

A new cytofluorimetric approach to evaluate the circulating microparticles in subjects with antiphospholipid antibodies.

Intra-tumoral IFN-γ-producing Th22 cells correlate with TNM staging and the worst outcomes in pancreatic cancer.

Designing a broad-spectrum integrative approach for cancer prevention and treatment.

Protein disulfide isomerase A3-specific Th1 effector cells infiltrate colon cancer tissue of patients with circulating anti-protein disulfide isomerase A3 autoantibodies.

Peripheral ENO1-specific T cells mirror the intratumoral immune response and their presence is a potential prognostic factor for pancreatic adenocarcinoma.

The interplay between the microbiome and the adaptive immune response in cancer development.

Macrophages and Neutrophils: Regulation of the Inflammatory Microenvironment in Autoimmunity and Cancer.

β2 Glycoprotein I Recognition Drives Th1 Inflammation in Atherosclerotic Plaques of Patients with Primary Antiphospholipid Syndrome.

Treatment of colon cancer cells with 5-fluorouracil can improve the effectiveness of RNA-transfected antitumor dendritic cell vaccine.

Preliminary Comparison of Oral and Intestinal Human Microbiota in Patients with Colorectal Cancer: A Pilot Study.

The Different Functional Distribution of "Not Effector" T Cells (Treg/Tnull) in Colorectal Cancer.

The controversial role of in colorectal cancer.

Gut Inflammatory Diseases, Infection, and Nutrition.

I've A Feeling: Microbiota Impacting the Conceptual and Experimental Perspectives of Personalized Medicine.

Editorial: Immune Checkpoint Molecules and Cancer Immunotherapy.

The Gut⁻Brain Axis in the Neuropsychological Disease Model of Obesity: A Classical Movie Revised by the Emerging Director "Microbiome".

Gut-Liver Axis, Gut Microbiota, and Its Modulation in the Management of Liver Diseases: A Review of the Literature.

Role of diet and gut microbiota on colorectal cancer immunomodulation.

Differential Responses of Colorectal Cancer Cell Lines to Strains Isolated from Healthy Donors and Colorectal Cancer Patients.

Influence of a 3-month low-calorie Mediterranean diet compared to the vegetarian diet on human gut microbiota and SCFA: the CARDIVEG Study.

Editorial of Special Issue "The Interplay of Microbiome and Immune Response in Health and Diseases".

Healthy axis: Towards an integrated view of the gut-brain health.

Evaluation and comparison of short chain fatty acids composition in gut diseases.

Effect of Probiotics on Oral Candidiasis: A Systematic Review and Meta-Analysis.

FETR-ALS Study Protocol: A Randomized Clinical Trial of Fecal Microbiota Transplantation in Amyotrophic Lateral Sclerosis.

The lung microbiome: clinical and therapeutic implications.

Potential therapeutic strategies to target gut microbiota in hepatocellular carcinoma.

Circulating Metabolites Originating from Gut Microbiota Control Endothelial Cell Function.

Hydrogen Sulfide Effects on the Survival of Lactobacilli with Emphasis on the Development of Inflammatory Bowel Diseases.

Immunomodulating Activity and Therapeutic Effects of Short Chain Fatty Acids and Tryptophan Post-biotics in Inflammatory Bowel Disease.

The link "Cancer and autoimmune diseases" in the light of microbiota: Evidence of a potential culprit.

Not just 'immunity': how the microbiota can reshape our approach to cancer immunotherapy.

Calcific Aortic Valve Disease-Natural History and Future Therapeutic Strategies.

Effectiveness of a Khorasan Wheat-Based Replacement on Pain Symptoms and Quality of Life in Patients with Fibromyalgia.

Role of gut microbiota-immunity axis in patients undergoing surgery for colorectal cancer: Focus on short and long-term outcomes.

Metabolomics profile in gastrointestinal cancers: Update and future perspectives.

A Structurally Simple Vaccine Candidate Reduces Progression and Dissemination of Triple-Negative Breast Cancer.

Immune Landscape in Tumor Microenvironment: Implications for Biomarker Development and Immunotherapy.

Exploring the food-gut axis in immunotherapy response of cancer patients.

Faecal microbiota transplant from aged donor mice affects spatial learning and memory via modulating hippocampal synaptic plasticity- and neurotransmission-related proteins in young recipients.

Editorial: Gut Microbiota and Inflammation: Relevance in Cancer and Cardiovascular Disease.

Significant and Conflicting Correlation of IL-9 With and in Human Colorectal Cancer.